Timothy Pierce
Family · New York, NYNPI 1922631258
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 224 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,827, more than ten times the $62 reported in 2021. Among family clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $24.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$915
- AbbVie$744
- Lilly USA, LLC$739
- AstraZeneca$622
- Gilead$326
- Corium, LLC$268
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,32099%
- Education$581%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 39 | $915 |
| AbbVie | 32 | $744 |
| Lilly USA, LLC | 33 | $739 |
| AstraZeneca | 28 | $622 |
| Gilead | 6 | $326 |
| Corium, LLC | 11 | $268 |
| Exact Sciences | 9 | $222 |
| Axsome Therapeutics, Inc. | 8 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $172 |
| Novo Nordisk | 8 | $163 |
| Almatica Pharma LLC | 5 | $123 |
| Idorsia Pharmaceuticals US Inc | 4 | $115 |
| Bausch Health US, LLC | 5 | $114 |
| Merck | 4 | $104 |
| Amgen | 3 | $90 |
| GSK | 4 | $76 |
| Pfizer | 2 | $51 |
| Kaleo, Inc. | 2 | $50 |
| Dexcom, Inc. | 1 | $47 |
| Astellas Pharma US Inc | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 1 | $29 |
| Itamar Medical Inc | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Shield Therapeutics Inc | 1 | $25 |
| Intra-sana Laboratories | 1 | $21 |
| Genentech USA, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Abbott | 1 | $17 |
| Phadia US Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,378 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Zolpidem Tartrate | 23 | $114 |
Paid to pharmacies, not to this prescriber.
Other family in New York
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Mary Sullivan-WhalenNew York$137K
- Leslie WoronaNew York$77K
- Thomas SaglimbeniNew York$48K
- Kathryn JohnsonNew York$48K
- Derek PinedaNew York$38K
- Rebecca SchoriNew York$32K
- Evangelia NezisNew York$22K
- Colette NelsonNew York$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.